Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WWC1 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-06 |
mRNA | LAMA5 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
mRNA | EPS8L2 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-05 |
mRNA | NBR1 | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
mRNA | DNAJB2 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
mRNA | MANBAL | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
mRNA | TM9SF4 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | CEP295NL | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
mRNA | CYTH3 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
mRNA | NEDD9 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |